C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/29/2007	US20070275464 Chitin Oligosaccharide Elicitor-Binding Proteins
11/29/2007	US20070275462 Human Prostate Cancer Cell Factor(s) that Induce Stem Cell Commitment and Osteogenesis
11/29/2007	US20070275460 Immunogllobulin for use in tissue directed antibody dependent cell-mediated phagocytosis and/or antibody dependent cell-mediated cytotoxicity (ADCC) treatment of cancer, inflammation and cardiovascular disease; immunotherapeutics
11/29/2007	US20070275441 Ocular Tissue Modification
11/29/2007	US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007	US20070275439 Methods To Obtain Recombinant Proteins With Increased Sialylation From Cells That Express Adenovirus E1a Protein, And Proteins Obtained Thereby
11/29/2007	US20070275437 Antibodies to G protein-coupled receptor
11/29/2007	US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/29/2007	US20070275432 Means for a Quantitative Detection of Cytochrome C
11/29/2007	US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007	US20070275419 Tumor tag and the use thereof
11/29/2007	US20070275418 Immunoglobulin for detecting fetal red blood cells in maternal blood; diagnosing chromosomal or genetic defects in developing fetus
11/29/2007	US20070275417 Cd4+ Epitopes of Bone Morphogenetic Proteins
11/29/2007	US20070275408 Synthetic Bioelastomer
11/29/2007	US20070275401 USE OF Mx GTPASES IN THE PROGNOSIS AND TREATMENT OF CANCER
11/29/2007	US20070275393 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
11/29/2007	US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007	US20070275385 Rapid Screening Method of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom
11/29/2007	US20070275384 Assessing human predisposition to a febrile seizure disorder
11/29/2007	US20070275379 Simian Orl1 Gene and Method of Assessing Compound
11/29/2007	US20070275377 Isolated Photoprotein mtClytin, and Use Thereof
11/29/2007	US20070275368 Posh Associated Kinases And Related Methods
11/29/2007	US20070275367 Type lectin fold as a scaffold for massive sequence variation
11/29/2007	US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007	US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007	US20070275037 Recombinant vitellogenin enriched feed
11/29/2007	US20070275026 Therapeutic Use of a Growth Factor, NsG33
11/29/2007	US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007	US20070275017 Identification of Antigenically Important Neisseria Antigens by Screening Insertional Mutant Libraries with Antiserum
11/29/2007	US20070275016 Kennel cough vaccine
11/29/2007	US20070275015 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
11/29/2007	US20070275012 Pharmaceutical Compositions for Therapeutic Use
11/29/2007	US20070275010 Mva Vaccines
11/29/2007	US20070275004 Group b streptococcus antigens
11/29/2007	US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007	US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007	US20070275001 Rational Design and Engineering of Proteins and Peptides for Immunomodulation
11/29/2007	US20070275000 Tick Engorgement Factor Proteins
11/29/2007	US20070274995 Cardiotrophin-1 compositions and methods for the treatment of tumor
11/29/2007	US20070274994 Virulence-Associated Adhesins
11/29/2007	US20070274992 Secreted Protein Family
11/29/2007	US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007	US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007	US20070274987 Expression of the cysteine protease legumain in vascular and inflammatory diseases
11/29/2007	US20070274972 Polypeptide having fungicidal activity against Colletotrichum, Diplodia, or Fusarium; applying by spraying, dusting, seed coating or broadcasting; transformed plants, cells, microorganisms and seeds
11/29/2007	US20070274971 Method of Proliferating Precursor Cells
11/29/2007	US20070274969 Immortalization of Mammalian Cells
11/29/2007	US20070274950 Interferon-alpha polypeptides and conjugates
11/29/2007	US20070274931 sunscreen formulation comprising a peptide-based metal oxide sunscreen agent such as titanium dioxide nanoparticles, and a fluid vehicle; has low toxicity and is non-irritating to the skin; improved durability for long lasting effects
11/29/2007	US20070274918 Software system using a three-dimensional model of a crystal LINGO-1 polypeptide to design an agent that binds LINGO-1 and disables the Nogo; receptor complex; LINGO-1 signaling a negative regulator of myelin production; Lingo-1 antagonists; drug design; multiple sclerosis
11/29/2007	US20070274914 Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
11/29/2007	US20070274885 Fractal-Forming Alkylketene Dimers For Integral Membrane Protein Crystal Growth
11/29/2007	US20070272998 Semiconductor Device
11/29/2007	DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007	CA2670804A1 Immunological composition
11/29/2007	CA2652595A1 Defective interfering virus
11/29/2007	CA2652578A1 Erythropoietin compositions
11/29/2007	CA2652538A1 Fusion proteins, uses thereof and processes for producing same
11/29/2007	CA2650414A1 Methods and compositions for inactivation of dihydrofolate reductase
11/29/2007	CA2649722A1 Use of an antibody
11/29/2007	CA2590552A1 Methods and compositions for depleting mitochondrial dna
11/28/2007	EP1860438A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein
11/28/2007	EP1860199A2 Modulating insulin receptor signaling
11/28/2007	EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007	EP1860191A2 Combination neisserial compositions
11/28/2007	EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007	EP1860189A1 Human gene
11/28/2007	EP1860188A2 Human cytokine receptor
11/28/2007	EP1860187A1 Apo-2 receptor
11/28/2007	EP1860186A2 Method for distinguishing mesenchymal stem cells using different markers
11/28/2007	EP1860185A1 Screening method
11/28/2007	EP1860184A1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide
11/28/2007	EP1860182A1 Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof
11/28/2007	EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007	EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007	EP1859818A1 Complex for biocompatible material and process for production thereof
11/28/2007	EP1859805A2 Peptides and peptide analogues designed from the HFE protein and their uses in the treatment of iron overload diseases
11/28/2007	EP1859277A2 Treating neurological disorders
11/28/2007	EP1859063A2 Replikin peptides and uses thereof
11/28/2007	EP1859041A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
11/28/2007	EP1858927A2 Methods and uses of antibodies in the purification of interferon
11/28/2007	EP1858924A1 Methods of treating skin disorders using an il-31ra antagonist
11/28/2007	EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007	EP1858922A2 A novel component of the wg/wnt signaling pathway
11/28/2007	EP1858921A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators
11/28/2007	EP1858920A2 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
11/28/2007	EP1858919A2 Immunogens from uropathogenic escherichia coli
11/28/2007	EP1858918A1 Nucleic acid fragments and specific detection method by molecular identification of different bacteria species of the genus acinetobacter
11/28/2007	EP1858917A2 Varicella zoster virus vaccine
11/28/2007	EP1858916A1 Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
11/28/2007	EP1858915A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
11/28/2007	EP1858914A1 Peptide networks
11/28/2007	EP1858549A2 Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing an immune response
11/28/2007	EP1858546A2 Modified transferrin fusion proteins
11/28/2007	EP1858532A1 Compositions and methods for less immunogenic protein formulations
11/28/2007	EP1858355A1 High pressure processing of metal ion lactoferrin
11/28/2007	EP1713511A4 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
11/28/2007	EP1691844A4 Methods and compositions for treatment of interferon-resistant tumors
11/28/2007	EP1625199A4 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
11/28/2007	EP1601689B1 Purification process for bacterial cytolysin

1 ... 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 ... 2916